GeoVax Labs Inc (GOVX)

NASDAQ
5.95
-0.35(-5.56%)
After Hours
6.00
+0.05(+0.8403%)
- Delayed Data
  • Volume:
    516,443
  • Bid/Ask:
    5.90/6.00
  • Day's Range:
    5.56 - 6.09

GOVX Overview

Prev. Close
6.3
Day's Range
5.56 - 6.09
Revenue
1.83M
Open
5.81
52 wk Range
0.23 - 8.68
EPS
-4.28
Volume
516,443
Market Cap
37.58M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
1,242,774
P/E Ratio
-
Beta
1.75
1-Year Change
1,094.78%
Shares Outstanding
6,316,702
Next Earnings Date
-
What is your sentiment on GeoVax Labs Inc?
or
Market is currently closed. Voting is open during market hours.

GeoVax Labs Inc News

GeoVax Labs Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyStrong BuyBuySell
Technical IndicatorsStrong BuyStrong BuyBuyStrong BuyBuy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyNeutral

GeoVax Labs Inc Company Profile

GeoVax Labs Inc Company Profile

Employees
8

GeoVax Labs, Inc. (GeoVax) is a clinical-stage biotechnology company. The Company is engaged in developing human vaccines against infectious diseases using its modified vaccine Ankara-virus-like particles (MVA-VLP) vaccine platform. The Company's platform supports in vivo expression of non-infectious virus-like particles (VLPs) from the cells of the person receiving the vaccine. The Company's development programs are focused on vaccines against Human Immunodeficiency Virus (HIV), Zika virus and hemorrhagic fever viruses (Ebola, Marburg and Lassa Fever), as well as for use in cancer immunotherapy. The Company's clinically advanced vaccine development program is a (deoxyribonucleic acid (DNA)/MVA) vaccine regimen designed to protect against the clade B subtype of the HIV virus. The Company is developing a Tetravalent Vaccine (TV) utilizing its MVA-VLP platform to address the unmet need for a product that can respond to future filovirus epidemics.

Read More
  • Start the party 🎉 🎉
    0
    • making four vaccine looking good
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.